TSX:WELLHealthcare
Does WELL’s Revenue Surge And 2026 Outlook Change The Bull Case For WELL Health Technologies (TSX:WELL)?
In March 2026, WELL Health Technologies Corp. reported full-year 2025 results showing sales of CA$1.40 billion, up from CA$919.69 million, alongside a net loss of CA$7.36 million versus net income of CA$32.61 million a year earlier.
The shift from earnings per share of CA$0.13 to a loss per share of CA$0.03 highlights pressure on profitability despite substantial revenue expansion.
We’ll now examine how WELL’s move to a small net loss alongside 2026 revenue guidance of...